Pembrolizumab trials for TNBC - Triple-Negative Breast Cancer

All Pembrolizumab trials · All TNBC - Triple-Negative Breast Cancer trials

Phase breakdown

Recruiting trials studying Pembrolizumab for TNBC - Triple-Negative Breast Cancer

• A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer
  NCT04683679 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female · 7 locations
• Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast Cancer
  NCT06637306 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Reinvigorating TNBC Response to Immunotherapy With Combination Myeloid Inhibition and Radiation
  NCT05491226 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female · 1 location

Common questions

How many trials study Pembrolizumab for TNBC - Triple-Negative Breast Cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.